Amgen, Inc.
(NASDAQ : AMGN)

( )
AMGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.71%203.211.3%$436.19m
BIIBBiogen Inc.
0.73%227.721.3%$386.27m
GILDGilead Sciences, Inc.
0.08%65.350.9%$368.51m
CELGCelgene Corporation
0.02%100.971.3%$353.70m
ILMNIllumina, Inc.
-0.80%309.673.5%$257.96m
REGNRegeneron Pharmaceuticals, Inc.
-1.46%299.402.6%$220.44m
EXASExact Sciences Corporation
-2.17%97.5824.1%$205.36m
ALXNAlexion Pharmaceuticals, Inc.
-5.06%99.512.0%$180.57m
VRTXVertex Pharmaceuticals Incorporated
-0.03%176.091.9%$177.48m
AAgilent Technologies, Inc.
-0.65%75.261.6%$148.26m
SRPTSarepta Therapeutics, Inc.
-1.49%86.7414.6%$140.12m
BMRNBioMarin Pharmaceutical Inc.
-0.83%67.944.3%$95.23m
ALDRAlder Biopharmaceuticals, Inc.
-0.05%18.8710.2%$90.77m
SGENSeattle Genetics, Inc.
0.58%83.866.2%$87.50m
NKTRNektar Therapeutics
1.42%17.545.5%$85.01m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.